Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 16089217 | HCID 16089217 | — |
| Solvent | Ammonia | HCID 222 | — |
| Product | Cladribine | HCID 20279 | — |
Reaction Steps
A solution of 2-chloro-9-[2-deoxy-3,5-di-O-(p-toluoyl)-β-D-erythro-pentofuranosyl]-6-(2-pentylimidazol-1-yl)purine (0.35 g, 0.55 mmol) in methanolic ammonia (14%) was stirred at 80° C. for 13 h. Volatiles were evaporated, and the oily residue was extracted with CH2Cl2 (10 mL) to remove lipophilic by-products. The semi-solid residue was dissolved in acetone (with additions of small amounts of MeOH—if necessary), volatiles were evaporated, and the semi-solid was allowed to crystallize (˜1 h). This material was extracted with CH2Cl2 (10 mL) and dried. The resulting 2-chloro-2′-deoxyadenosine (white powder; 113 mg, 70%) was pure by 1H NMR analysis. Additional amounts of cladribine (˜24 mg, 15%; containing traces of the α-anomer) were recovered from the concentrated extracts by chromatography (EtOAc→EtOAc/MeOH, 10:1) followed by a similar extraction sequence.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07855285B2 |
|---|
| Source dataset | uspto-grants-2010_12 |
|---|
| ORD ID | ord-46f14745b5a348259a3a6b8b2ed81a83 |
|---|
| Source note | uspto-grants-2010_12 |
|---|